1Kukreja A,Cost G,Marker J et al.Multiple immuno-regulatory defects in type-1 diabetes[J].J Clin Invest,2002;109(1):131-140.
2Brusko T M,Wasserfall C H,Clare-Salzler M J et al.Functional defects and the influence of age on the frequency of CD4^+CD25^+ T cells in Type 1 Diabetes[J].Diabetes,2005;54(5):1407-1414.
3Von B H.Mechanisms of suppression by suppressor T cells[J].Nat Immunol,2005;6:338-344.
4Shevach E M,Mchugh R S,Piccrillo C A et al.Control of T-cell activation by CD4+CD25+ suppressor T cells[J].Immunol Rev,2001;182:58-67.
5Thornton A M,Shevach E M.CD4^+CD25^+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production[J].J Exp Med,1998;188(2):287-296.
6Hontsu S,Yoneyama H,Ueha S et al.Visualization of naturally occurring Foxp3+ regulatory T cells in normal and tumor-bearing mice[J].Int Immunol,2004;4(14):1785-1793.
7Read S,Malmstrom V,Powrie F.Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25^+CD4^+ regulatory cells that control intestinal inflammation[J].J Exp Med,2000;192(2):295-302.
8Taylor P A,Lees C J,Fournier S et al.B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions[J].J Immunol,2004;172(1):34-39.
9Herman A E,Freeman G J,Mathis D et al.CD4^+CD25^+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion[J].J Exp Med,2004;199(11):1479-1489.
10Pae H O,Oh G S,Choi B M et al.Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production[J].J Immunol,2004;172(8):4744-4751.
5Kaufman A,Herold KC. Anti-CD3 mAbs for treatment of type 1 diabetes[J]. Diabetes Metab Res Rev,2009,25(4) :302-306.
6Adebayo AH, Tan NH, Akindahunsi AA, et al. Anticancer and antiradical scavenging activity of Ageratum conyzoides L. (Asteraceae)[J]. Phcog Mag, 2010,6(21) : 62-66.
